Cannabidiol as a harm reduction strategy for people who use drugs: a rapid review

LA Lo, CA MacCallum, K Nanson… - The Canadian …, 2023 - journals.sagepub.com
Objective The drug poisoning crisis throughout North America necessitates novel harm
reduction approaches. Emerging evidence suggests that cannabidiol (CBD) may have some …

Use and perceptions of Cannabidiol among individuals in treatment for opioid use disorder

C Kudrich, R Chen, Y Meng, K Bachi, YL Hurd - Harm Reduction Journal, 2024 - Springer
Background Cannabidiol (CBD) is a widely available cannabis product with many claims as
to potential health benefits including alleviating symptoms related to opioid use disorder …

Cannabidiol in the context of substance use disorder treatment: A systematic review

V Paulus, J Billieux, A Benyamina, L Karila - Addictive behaviors, 2022 - Elsevier
Introduction Cannabidiol (CBD) is a phytocannabinoid found in the Cannabis plant. CBD
has received significant medical attention in relation to its anticonvulsant, anxiolytic, and …

Cannabidiol and substance use disorder: Dream or reality

S Karimi-Haghighi, Y Razavi, D Iezzi, AF Scheyer… - …, 2022 - Elsevier
Background Cannabidiol (CBD) is one of the major constituents of Cannabis sativa L. that
lacks psychotomimetic and rewarding properties and inhibits the rewarding and reinforcing …

Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence

M Prud'homme, R Cata… - … abuse: research and …, 2015 - journals.sagepub.com
Drug addiction is a chronically relapsing disorder characterized by the compulsive desire to
use drugs and a loss of control over consumption. Cannabidiol (CBD), the second most …

Cannabidiol for the reduction of cue-induced craving and anxiety in drug-abstinent individuals with heroin use disorder: a double-blind randomized placebo-controlled …

YL Hurd, S Spriggs, J Alishayev… - American Journal of …, 2019 - Am Psychiatric Assoc
Objective: Despite the staggering consequences of the opioid epidemic, limited nonopioid
medication options have been developed to treat this medical and public health crisis. This …

A cross-sectional study of cannabidiol users

J Corroon, JA Phillips - Cannabis and cannabinoid research, 2018 - liebertpub.com
Introduction: Preclinical and clinical studies suggest that cannabidiol (CBD) found in
Cannabis spp. has broad therapeutic value. CBD products can currently be purchased …

Cannabidiol (CBD) use in psychiatric disorders: A systematic review

S Bonaccorso, A Ricciardi, C Zangani, S Chiappini… - Neurotoxicology, 2019 - Elsevier
Abstract Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the most represented
phytocannabinoids in Cannabis sativa plants. However, CBD may present with a different …

[HTML][HTML] Cannabidiol usage, efficacy, and side effects: analyzing the impact of health conditions, medications, and cannabis use in a cross-sectional online pilot study

AA Binkowska, N Jakubowska, A Redeł… - Frontiers in …, 2024 - frontiersin.org
Background Products containing cannabidiol (CBD) are attracting attention because of their
potential therapeutic benefits and positive impacts on well-being and mental health …

Cannabidiol for the treatment of drug use disorders

RG dos Santos, JEC Hallak, AW Zuardi… - Handbook of Cannabis …, 2017 - Elsevier
The problematic use of psychoactive substances like alcohol, cannabis, cocaine,
amphetamines, heroin, and nicotine carry a series of health, economic, and social costs to …